55513-100 : Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution


NDC: 55513-100
Labeler: Amgen, Inc
Product Type: Human Prescription Drug
Drug Name:  Tezspire
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761224
Rev. Date: 


NDC Package Codes:

  • 55513-100-01: 1 VIAL, GLASS IN 1 CARTON (55513‑100‑01) > 1.91 ML IN 1 VIAL, GLASS
  • 55513-100-96: 1 VIAL, GLASS IN 1 CARTON (55513‑100‑96) > 1.91 ML IN 1 VIAL, GLASS
  • 55513-100-99: 1.91 ML IN 1 VIAL, GLASS (55513‑100‑99)

Active Ingredients:

  • Tezepelumab

Dosage Strength:

  • 210 mg/1.9mL

Pharmaceutical Classes:

  • Thymic Stromal Lymphopoietin Blocker [EPC]
  • Thymic Stromal Lymphopoietin Blockers [MoA]

Related Products:

Based on records with the same trade name.
  • 55513-112 Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution by Amgen, Inc
  • 55513-123 Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution by Amgen, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-100 QR Code

< Prev: 55513-098Next: 55513-110 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.